Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference
Tectonic Therapeutic plans a fireside chat and one-on-one investor meetings at the Morgan Stanley Global Healthcare Conference with webcast and replay access.
Rhea-AI Summary
Tectonic Therapeutic (TECX) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026 in New York, NY.
President and CEO Alise Reicin, MD, is scheduled for a fireside chat at 5:35 PM ET, which will be webcast live and accessible via the Investors section of the company’s website. A replay will be available for approximately 90 days, and management will also hold one-on-one investor meetings during the conference.
Positive
- None.
Negative
- None.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Aug 06 | Q2 earnings | Positive | +2.5% | Reported Q2 results, APEX enrollment completion, TX2100 dosing, and cash runway into Q1 2029. |
| Jun 10 | Phase 2 enrollment | Positive | +4.6% | Completed enrollment in 24-week APEX Phase 2 trial across 14 countries. |
| May 07 | Q1 earnings | Positive | +7.9% | Reported Q1 results, pipeline progress, leadership additions, and cash runway into Q4 2028. |
| Apr 23 | Board appointment | Positive | +0.3% | Appointed Jessica Chutter to board, effective June 8, 2026, citing healthcare banking experience. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Each selected historical announcement had a positive 24-hour price reaction.
Key Terms
gpcrs technical
g-protein coupled receptors technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
WATERTOWN, Mass., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced that Alise Reicin, MD, President and Chief Executive Officer, will participate in a fireside chat at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference.
Morgan Stanley 24th Annual Global Healthcare Conference
| Date: | September 14, 2026 |
| Time: | 5:35 PM ET |
| Location: | New York, NY |
| Format: | Fireside Chat |
| Presenter: | Alise Reicin, MD, President and Chief Executive Officer |
| Webcast: | Link |
The live fireside chat can also be accessed under “Events & Presentations” on the Investors section of the Tectonic website at www.tectonictx.com. Once the live event has concluded, a replay of the event will be available on the Company’s website for approximately 90 days.
The Tectonic management team will host one-on-one meetings during the conference. Interested investors should contact their Morgan Stanley representative to schedule meetings.
About Tectonic
Tectonic Therapeutic is a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Leveraging its proprietary technology platform called GEODe™ (GPCRs Engineered for Optimal Discovery), Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery and harness the human body to modify the course of disease. Tectonic focuses on areas of significant unmet medical need, often where therapeutic options are poor or nonexistent, as these are areas where new medicines have the potential to improve patient quality of life. Tectonic is headquartered in Watertown, Massachusetts. For more information, please visit www.tectonictx.com and follow us on LinkedIn.
Contacts: Investors: Dan Ferry LifeSci Advisors (617) 430-7576 daniel@lifesciadvisors.com Media: Kathryn Morris The Yates Network (914) 204-6412 kathryn@theyatesnetwork.com